Announces Achievement Of Preclinical Proof-Of-Concept Milestone Using J-Brain Cargo Technology For Lysosomal Storage Disorder In Gene Therapy Collaboration With Takeda

JCR Pharmaceuticals

28/03/2023 08:02

March 28 (Reuters) - Takeda Pharmaceutical Co Ltd
 4502.T :
    * JCR PHARMACEUTICALS CO LTD: ANNOUNCES ACHIEVEMENT OF
PRECLINICAL
PROOF-OF-CONCEPT MILESTONE USING J-BRAIN CARGO TECHNOLOGY FOR
LYSOSOMAL STORAGE DISORDER IN GENE THERAPY COLLABORATION WITH
TAKEDA

Source text for Eikon:  ID:nTSob833fa 
Further company coverage:  4502.T 

 (Reporting by Tokyo Newsroom)
 ((+81345201189;))